Advarra

AUGUST 8, 2024

The EU AI Act’s implications extend into clinical research, where AI is increasingly utilized for tasks like medical image analysis, natural language process for endpoint analysis, and generating/analyzing data for synthetic control arms. Non-EU companies must comply with the AI Act if their AI systems are used in the EU market.

Clinical Research 98

Clinical Research Research Clinical Trials Compliance 98

PPD

OCTOBER 31, 2024

In response, the PPD clinical research business of Thermo Fisher Scientific conducted its third global survey of 150 drug developers to capture a comprehensive view of these evolving trends. Small/mid-size participants in particular indicate greater use of DCTs, expecting higher use by 2026.

Drug Development 52

Drug Development Clinical Trials Trials Drugs 52

Alta Sciences

JANUARY 31, 2025

Their passion and curiosity to expand the boundaries of toxicology research illuminated the room. As experts in early-phase drug development , from discovery through Phase II clinical research , we at Altasciences can share with STC members our accumulated knowledge and experience, and provide mentorship for future toxicologists.

Cell Biology 52

Cell Biology Pharmaceutical Companies Clinical Research Government 52

The Pharma Data

NOVEMBER 11, 2020

and EU5 by 2026. The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. The DSR therapy is not currently approved for clinical research in the United States or Canada.

Therapies 40

Therapies Disease Marketing Clinical Research 40

The Pharma Data

OCTOBER 14, 2020

He is Director of Cardiovascular Research at the Duke Clinical Research Institute and Vice-Chief for Clinical Research in the Division of Cardiology. and EU5 by 2026. The DSR therapy is not currently approved for clinical research in the United States or Canada.

Clinical Trials 40

Clinical Trials Therapies Clinical Research Trials 40

The Pharma Data

DECEMBER 16, 2020

and EU5 by 2026. The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. The DSR therapy is not currently approved for clinical research in the United States or Canada.

Therapies 40

Therapies Disease Marketing Clinical Research 40

Agency IQ

AUGUST 16, 2024

FDA released a draft guidance in June 2023 attempting to address many of these unique aspects of clinical research on psychedelic substances. The study is planned to begin in 2026 and conclude in 2028. Read AgencyIQ analysis here for a detailed discussion of these issues. ]. See AgencyIQ’s analysis of the draft guidance here. ].

FDA 40

FDA Trials Therapies Regulations 40